Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report.

Manabu MiyataAkio OishiMaho OishiTomoko HasegawaHanako Ohashi IkedaAkitaka Tsujikawa

Published in: BMC ophthalmology (2018)

No negative effects related to the progression of visual field loss were observed during continuous treatment with anti-VEGF agents for 8 years in our patient.

Keyphrases

vascular endothelial growth factor
endothelial cells
case report
mesenchymal stem cells
bone marrow
replacement therapy